Articles & Video
Let the Northern Lights Illuminate your BIO-Europe® Partnering
Making a plan for BIO-Europe digital in October? This time around we were almost going to be in Stockholm, one of the glittering capitals in the Nordics. But the world doesn’t seem quite ready to kick off its comfy Zoom slippers and try on some new work shoes to walk the walk, as well as talk the talk, for international biotech partnering. But even if we can’t be there in person, we can be there in spirit. Here’s some advice to add a little Nordic magic to your BIO-Europe partnering.
Venture Capital Has Advanced Innovation in China Life Science; It Needs to Do More
At the recent ChinaBio® Partnering Forum, a group of China VCs discussed their very vibrant field: $30 billion in VC investments last year, double the year before.
Alkermes: Driving Ambition in the Innovative Neuroscience and Oncology Space
In this interview, Blair Jackson, COO, Alkermes, speaks with Informa Connect’s Xconomy to discuss the rationale behind Alkermes’ evolving strategy in neuroscience and oncology and the ambition to be a major innovator in the competitive pharmaceutical landscape.
The COVID-19 pandemic has changed public perception of the European Biotech sector
In advance of BIO-Europe Spring® Digital 2021, we talked to conference attendees about recent changes in the sector and in their own companies to gain a glimpse of what the future might hold. As you would expect from this crowd, we got some very insightful answers and are happy to share them here.
The Key to Playing Harmoniously at BIO-Europe Spring® Digital 2021
Can it really be almost a whole year since BIO-Europe Spring® 2020 went digital? In Groundhog Day, Bill Murray had become a concert pianist by this point in the film, having relived the same day several hundred times over, but wisely spending a little time each day to practice the piano, so he could successfully woo his partner of choice. So, a year on with digital partnering are you now skillful at Chopin or struggling at chopsticks?
Moment of truth: Term sheet negotiations reveal more than you might expect
The thought of negotiating the terms and conditions for a partnership with a pharma company or other third party is often full of ambiguity or anxiety for biotech innovators and executives. But when approached with the right mindset, the process can provide critical insights while smoothing the way for contract negotiations down the road.